IGF2BP2 and head and neck squamous cell carcinoma: Subsequent ChIP-qPCR analysis also verified that JQ1 or CPI-637 treatment significantly reduced the enrichment of BRD4 or H3K27Ac at IGF2BP2-SE in HNSCC cells, respectively.